In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i>_NDM, <i>bla</i>_KPC, and ESBL-Producing Enterobacteriales Uropathogens

• Autores principales: Lubna Razaq (Autor), Fakhur Uddin (Autor), Shahzad Ali (Autor), Shah Muhammad Abbasi (Autor), Muhammad Sohail (Autor), Nabila E. Yousif (Autor), Hala M. Abo-Dief (Autor), Zeinhom M. El-Bahy (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2023-09-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infe...